- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01529281
Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids
February 6, 2012 updated by: Northumbria University
It is well documented that exercise-induced muscle damage (EIMD) decreases muscle function and causes severe soreness and discomfort.
Branched-chain amino acid (BCAA) supplementation has been shown to increase protein synthesis and decrease muscle protein breakdown, however, the effects of BCAAs on recovery from EIMD are unknown.
Thus, the aim of this study was to examine the effects of a BCAA supplement on markers of muscle damage.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Resistance trained males
Exclusion Criteria:
- Muscular skeletal disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BCAA
Branched chain amino acid
|
Supplementation lasted for a total of 12 days; this was based on previous research showing a positive with BCAA supplementation on markers of muscle damage.
Participants ingested 10 g, twice per day (morning and evening) of BCAA .
The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively).
The BCAA was in powder form where each serving was mixed with ~300 ml of water.
|
|
Placebo Comparator: Asparmate
Placebo control containing no protein or carbohydrate
|
Supplementation lasted for a total of 12 days.
Participants ingested an equivalent looking volume to 10 g of BCAA, twice per day (morning and evening) of placebo (aspartame based artificial sweetener).
The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively).
The artificial sweetener was in powder form where each serving was mixed with ~300 ml of water.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal voluntary contraction
Time Frame: pre exercise, 24 h, 48 h, 72 h, 96 h post-exercise
|
Isometric MVC of the participants' dominant knee extensors was assessed using a strain gauge.
MVCs were performed for 3 s with a 60 s rest between each repetition.
|
pre exercise, 24 h, 48 h, 72 h, 96 h post-exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Limb girths
Time Frame: pre-exercise, 24h, 48h, 72h, 96h
|
Mid-thigh and calf circumference was assessed as a measure of limb swelling using an anthropometric tape measure.
Both measures were obtained with the participant in a standing position.
|
pre-exercise, 24h, 48h, 72h, 96h
|
|
Vertical jump
Time Frame: pre-exercise, 24h, 48h, 72h, 96h
|
Vertical jump (VJ) performance was assessed using the Vertec instrument.
Participants performed a counter movement jump.
|
pre-exercise, 24h, 48h, 72h, 96h
|
|
Creatine kinase
Time Frame: pre-exercise, 24h, 48h, 72h, 96h
|
Plasma CK was determined from an earlobe capillary blood sample.
The sample (30 microlitres) was analysed immediately using an automated, dry slide photospectrometer.
|
pre-exercise, 24h, 48h, 72h, 96h
|
|
Muscle soreness
Time Frame: pre-exercise, 24h, 48h, 72h, 96h
|
Muscle soreness - Participants were asked to perform and hold a squat (90° knee angle) whilst they rated their perceived muscle soreness on a 200 mm visual analogue scale.
The scale consisted of a line from 0 mm (no pain) to 200 mm (unbearably painful).
|
pre-exercise, 24h, 48h, 72h, 96h
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
February 2, 2012
First Submitted That Met QC Criteria
February 6, 2012
First Posted (Estimate)
February 8, 2012
Study Record Updates
Last Update Posted (Estimate)
February 8, 2012
Last Update Submitted That Met QC Criteria
February 6, 2012
Last Verified
February 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- Northumbria_How_BCAA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise-induced Muscle Damage
-
St Mary's University CollegeNot yet recruitingExercise Induced Muscle Damage
-
Northumbria UniversityCompletedExercise Induced Muscle Damage
-
Vassilis PaschalisActive, not recruiting
-
Abbott NutritionCompleted
-
Swiss Federal Institute of TechnologyCompletedExercise Induced Muscle DamageSwitzerland
-
University of MinnesotaRecruitingExercise Induced Muscle Damage | Delayed Onset Muscle Soreness (DOMS)United States
-
St Mary's University CollegeCompletedExercise-induced Muscle DamageUnited Kingdom
-
Cairo UniversityCompletedAthletes | Rhabdomyolysis | Exercise-Induced Muscle DamageSaudi Arabia
-
University of Sistan and BaluchestanCompletedAthletic Injuries | Muscle Recovery | Exercise-induced Muscle Damage | Delayed-Onset Muscle Soreness (DOMS)Iran
-
Federal University of Health Science of Porto AlegreCompletedFatigue | Exercise-induced Muscle DamageBrazil
Clinical Trials on Branch Chain Amino Acid (BCAA)
-
University of California, Los AngelesCompletedGlucose Intolerance | Obese | Pre-diabetesUnited States
-
Louisiana State University Health Sciences Center...University Medical Center-New OrleansWithdrawnLiver Failure | Hepatocellular Carcinoma | CirrhosisUnited States
-
University of TorontoIovate Health Sciences International IncCompletedExercise | Metabolism | Amino Acids, EssentialCanada
-
SUUMC Central Military Hospital Dr Carol DavilaRecruiting
-
Mahidol UniversityEnrolling by invitationSarcopenia | Cirrhosis of the LiverThailand
-
University Hospital, GenevaCompleted
-
Institute of Liver and Biliary Sciences, IndiaRecruitingSarcopenia | Cirrhosis, LiverIndia
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Zhongda HospitalActive, not recruitingMyopia | Myopia ProgressingChina
-
VA Office of Research and DevelopmentChildren's Hospital of Philadelphia; Oregon Health and Science UniversityCompletedTraumatic Brain InjuryUnited States